Pharmarise Holdings Corporation (TYO:2796)

Pharmarise Holdings Revenue

Pharmarise Holdings had revenue of 16.85B JPY in the quarter ending November 30, 2025, with 10.03% growth. This brings the company's revenue in the last twelve months to 66.57B, up 14.65% year-over-year. In the fiscal year ending May 31, 2025, Pharmarise Holdings had annual revenue of 63.51B with 16.60% growth.

• Revenue (ttm): 66.57B
• Revenue Growth: +14.65%
• P/S Ratio: 0.09
• Revenue / Employee: 32.65M
• Employees: 2,039
• Market Cap: 6.02B

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2025	63.51B	9.04B	16.60%
May 31, 2024	54.47B	2.44B	4.68%
May 31, 2023	52.03B	422.00M	0.82%
May 31, 2022	51.61B	-716.00M	-1.37%
May 31, 2021	52.32B	1.29B	2.54%